View Clinical Trial (Medical Research Study)

Cannabis for Spasticity in Multiple Sclerosis - NCT00682929-95817(Clinical Trial 222521) has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


City: Sacramento
State: CA
Zip Code: 95817
Country: United States
Purpose: The purpose of this study is to learn if the use of inhaled cannabis (marijuana) and oral cannabinoid (dronabinol, Marinol or THC, which is an active ingredient of marijuana) is safe and effective in reducing the symptoms of spasticity and tremor in patients with secondary-progressive or primary progressive multiple sclerosis.
This page is no longer being updated. Please use our search for current trials or visit
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.